SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹237.3
- Today's High:
- ₹255.15
- Open Price:
- ₹251.55
- 52W Low:
- ₹160.5
- 52W High:
- ₹265.75
- Prev. Close:
- ₹253.5
- Volume:
- 119052
Company Statistics
- Market Cap.:
- ₹51.66 billion
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹488.44 million
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. had its IPO on under the ticker symbol SPARC.
The company operates in the sector and industry. SUN PHARMA ADVANCED RESEARCH COMPANY LTD. has a staff strength of 0 employees.
Stock update
Shares of SUN PHARMA ADVANCED RESEARCH COMPANY LTD. opened at ₹251.55 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹237.3 - ₹255.15, and closed at ₹239.05.
This is a -5.7% slip from the previous day's closing price.
A total volume of 119,052 shares were traded at the close of the day’s session.
In the last one week, shares of SUN PHARMA ADVANCED RESEARCH COMPANY LTD. have slipped by -4.15%.
SUN PHARMA ADVANCED RESEARCH COMPANY LTD.'s Key Ratios
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. has a market cap of ₹51.66 billion, indicating a price to book ratio of 33.5601 and a price to sales ratio of 42.7934.
In the last 12-months SUN PHARMA ADVANCED RESEARCH COMPANY LTD.’s revenue was ₹0 with a gross profit of ₹488.44 million and an EBITDA of ₹0. The EBITDA ratio measures SUN PHARMA ADVANCED RESEARCH COMPANY LTD.'s overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, SUN PHARMA ADVANCED RESEARCH COMPANY LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q4, SUN PHARMA ADVANCED RESEARCH COMPANY LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
SUN PHARMA ADVANCED RESEARCH COMPANY LTD.’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SUN PHARMA ADVANCED RESEARCH COMPANY LTD.’s profitability.
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. stock is trading at a EV to sales ratio of 45.2056 and a EV to EBITDA ratio of -30.5907. Its price to sales ratio in the trailing 12-months stood at 42.7934.
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹2.92 billion
- Total Liabilities
- ₹3.29 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. ended 2024 with ₹2.92 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹2.92 billion while shareholder equity stood at ₹-1186800000.00.
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹3.29 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹21.90 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
SUN PHARMA ADVANCED RESEARCH COMPANY LTD.’s total current assets stands at ₹734.00 million while long-term investments were ₹0 and short-term investments were ₹75.70 million. Its net receivables were ₹348.30 million compared to accounts payable of ₹1.21 billion and inventory worth ₹0.
In 2024, SUN PHARMA ADVANCED RESEARCH COMPANY LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, SUN PHARMA ADVANCED RESEARCH COMPANY LTD. paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹239.05
- 52-Week High
- ₹265.75
- 52-Week Low
- ₹160.5
- Analyst Target Price
- ₹
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. stock is currently trading at ₹239.05 per share. It touched a 52-week high of ₹265.75 and a 52-week low of ₹265.75. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹232.21 and 200-day moving average was ₹207.75 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.